OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 1 filers reported holding OCULAR THERAPEUTIX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393 | +207.0% | 125,200 | +403.0% | 0.00% | – |
| Q2 2023 | $128 | -65.9% | 24,893 | -65.0% | 0.00% | – |
| Q1 2023 | $375 | -54.6% | 71,193 | -75.8% | 0.00% | -100.0% |
| Q4 2022 | $826 | -98.6% | 293,993 | +1887.4% | 0.00% | – |
| Q3 2022 | $61,000 | -96.0% | 14,793 | -96.1% | 0.00% | -100.0% |
| Q2 2022 | $1,534,000 | -39.3% | 381,500 | -25.3% | 0.00% | -33.3% |
| Q1 2022 | $2,528,000 | +353.0% | 510,805 | +537.7% | 0.00% | +200.0% |
| Q4 2021 | $558,000 | -77.3% | 80,100 | -67.5% | 0.00% | -66.7% |
| Q3 2021 | $2,462,000 | -46.9% | 246,200 | -24.7% | 0.00% | -50.0% |
| Q2 2021 | $4,639,000 | +466.4% | 327,122 | +555.6% | 0.01% | +500.0% |
| Q1 2021 | $819,000 | -88.2% | 49,900 | -85.1% | 0.00% | -87.5% |
| Q4 2020 | $6,915,000 | +738.2% | 334,066 | +275.8% | 0.01% | +700.0% |
| Q1 2017 | $825,000 | -32.0% | 88,900 | -38.7% | 0.00% | -50.0% |
| Q4 2016 | $1,214,000 | +418.8% | 145,100 | +206.8% | 0.00% | – |
| Q2 2016 | $234,000 | +1.3% | 47,300 | +330.3% | 0.00% | -100.0% |
| Q2 2015 | $231,000 | – | 10,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |